Acute promyelocytic leukemia (APL) is characterized by reciprocal balanced chromosomal translocations involving retinoic acid receptor-a (RARa). RARa heterodimerizes with the retinoid X receptor-a (RXRa) and transcriptionally regulates myeloid differentiation in response to ATRA (all-trans retinoic acid). Several lines of evidence suggest that APL fusion proteins interact with RXRa. To elucidate the role of RXRa in APL, we conditionally knocked out RXRa in the hCG-NuMA-RARa APL mouse model. Phenotype analysis of NuMA-RARa þ mice demonstrated that these mice developed a myeloproliferative disease-like myeloid leukemia within 4 months of birth. While hemizygous and homozygous RXRa conditional knockout mice were phenotypically normal as late as 12 months of age, we observed that the leukemic phenotype in NuMA-RARa þ mice was dependent on the presence of functional RXRa. Bone marrow promyelocyte counts were significantly reduced in NuMA-RARa þ mice with RXRa knocked down. Significant differences in the accumulations of Gr-1 þ and Mac-1 þ cells were also seen. We further observed that genes previously identified to be cooperating events in APL were also regulated in an RXRa-dependent manner. We therefore propose that the APL fusion protein NuMA-RARa cooperates with RXRa in the development of leukemia in hCG-NuMA-RARa transgenic mice and suggest a novel role for RXRa in the pathogenesis of APL.
Introduction
Acute promyelocytic leukemia (APL) is characterized by impaired granulocytic differentiation, leading to promyelocyte accumulation in bone marrow (BM) and PB (peripheral blood; Bennett et al., 1976) , and sensitivity to ATRA (all-trans retinoic acid) (Castaigne et al., 1990) . APL is invariably associated with balanced translocations resulting in retinoic acid receptor-a (RARa) gene fusions. In addition to PML-RARa, present in >99% of cases (De The´et al., 1990) , six rare RARa partner genes have been identified (Chen et al., 1993; Redner et al., 1996; Wells et al., 1997; Arnould et al., 1999; Hummel et al., 1999; Macedo Silva et al., 2005; Catalano et al., 2007) . APL fusion proteins (X-RARa) act as aberrant transcriptional repressors on RA target genes by having stronger association with nuclear corepressors, thought to be due to homooligomerization (Minucci et al., 2000) .
The retinoid X receptors (RXRs) are obligate heterodimeric partners of multiple nuclear receptors, including RARa (Bugge et al., 1992) . The role of RXRa in APL is controversial. X-RARa form stable homodimers (Minucci et al., 2000) , leading to the hypothesis that X-RARa homodimers, rather than X-RARa/RXRa heterodimers, are the critical species in APL. However, other evidence suggests a key role for RXRa: PML-RARa is associated with nuclear complexes containing RXRa (Perez et al., 1993) . PML-RARa binds DNA in a complex with RXRa and represses transcription (Kamashev et al., 2004) . PLZFRARa/RXRa heterodimers bind to RAREs (retinoic acid response elements) with higher affinity than PLZF-RARa homodimers in vitro (Licht et al., 1996) . PLZF-RARa/ RXRa heterodimers also bind to nonconsensus RAREs, suggesting that these heterodimers contribute to APL pathogenesis through regulation of novel gene expression (So et al., 2000) . NPM-RARa and NuMA-RARa form heterodimers with RXRa; these complexes can bind and repress transcription from the RARE (Kamel-Reid et al., 2003) . Dimerization with RXRa is required for STAT5b-RARa-mediated transformation and DNA binding (Zeisig et al., 2007) , and for PML-RARa-mediated leukemogenesis in vivo (Zhu et al., 2007) .
We therefore modeled the loss of RXRa in hematopoietic cells by utilizing a conditionally targeted RXRa (Chen et al., 1998) in hCG-NuMA-RARa mice (Sukhai et al., 2004) . As with previous RXRa knockout models (Kastner et al., 1994; Chen et al., 1998; Li et al., 2000 Li et al., , 2001 Imai et al., 2001; Stephensen et al., 2007) , our model employed a conditional deletion of exon 4, encoding the DNA-binding domain. We report that loss of RXRa in the hCG-NuMA-RARa transgenic mice leads to amelioration of the leukemic phenotype, suggesting a role for RXRa in leukemia development. Cre/ þ offspring were observed, consistent with the reported viability of Flk1 þ /À animals (Shalaby et al., 1995) . We confirmed partial excision of RXRa exon 4 in Lin À progenitors from RXRa DDB/DDB mice ( Figure 2b ). Cre activity was also observed in CFU-GEMM (granulocyte/erythroid/macrophage/ megakaryocyte colony-forming unit) and granulocyte/ monocyte colony-forming unit (CFU-GM) colonies derived from RXRa DDB/DDB mice ( Figure 2a ). However, Cre activity was not uniform across individual colonies from a single mouse (30-85% of colonies exhibited RXRa DDB ). Furthermore, our analyses suggested that all colonies expressed Cre in a nuclear/ cytoplasmic distribution (Figure 2c) and NuMA-RARa þ /RXRa DDB/DDB mice had ameliorated phenotypes. The trend observed is similar to Figure 3a , where we specifically measured the proportion of promyelocytes in mouse BM. PB morphology and flow cytometry demonstrated a similar trend (not shown).
Results

Subcellular
The ameliorated BM morphology and immunophenotype evident in the NuMA-RARa þ /RXRa DDB/ þ and NuMA-RARa þ /RXRa DDB/DDB mice at 12 months, compared to NuMA-RARa þ /RXRa þ / þ controls, correlated with slower accumulation of promyelocytes (Figure 3a) . (Figure 4 ).
Gene expression analysis
Gcsfr expression was upregulated irrespective of RXR status, while Gmcsfr was upregulated in NuMA- Figure 5 ). Given these observations, the role of RXRa on NuMA-RARa transcriptional deregulation was assessed. We examined gene expression patterns of primary bone marrow cultures (PBMCs) established from all strains of mice used in this study and selected genes previously identified to be deregulated in APL (Bcl2 and Cebp family members; Kogan et al., 2001; Truong et al., 2003) . While Cebpe expression was reduced in NuMARARa þ /RXRa þ / þ cells, loss of RXRa function restored Cebpe expression to a more WT level ( Figure 6a) ; in contrast, Cebpa was downregulated in NuMA-
animals, but had WT expression levels in NuMARARa þ /RXRa DDB/ þ animals ( Figure 6b ). Another Cebp 
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Discussion
We report the effects of RXRa functional loss on leukemia development in hCG-NuMA-RARa mice. Our data are complementary to work suggesting that RXRa downregulation is required for G-CSF signaling in neutrophil differentiation (Taschner et al., 2007) . Our data are also consistent with very recent reports suggesting that dimerization with RXRa is essential for X-RARa oncogenicity (Zeisig et al., 2007; Zhu et al., 2007) . More importantly, our results indicate that functional loss of RXRa in the hCG-NuMA-RARa background ameliorates leukemia in these animals. We hypothesize that NuMA-RARa cooperates with functional RXRa during leukemogenesis in hCG-NuMARARa transgenic mice. We employed a conditional mutation in RXRa exon 4 using the Cre/LoxP system, which results in loss of the RXRa DNA-binding domain. The resultant truncated protein is cytoplasmic and incapable of activating transcription in response to 9-cis-RA, but is not dominant negative. Cre/ þ animals is heterogeneous; not all cells have active Cre recombinase. Furthermore, it is worthwhile to note that Cre-mediated RXRa excision is incomplete. A recent study demonstrated that Cre recombinase is toxic to cells at high concentration, as it results in genomic instability, altered DNA repair and subsequent apoptosis (Loonstra et al., 2001) . Thus, cells with low Cre activity may have a selective advantage over cells with high Cre activity, which may explain the moderate levels of RXRa exon 4 excision that we report. Furthermore, as some cells may have more Cre activity than others, it is reasonable to expect that RXRa DDB /RXRa WT ratios will also be (Taschner et al., 2007) suggested that RXRa downregulation is essential for terminal neutrophil differentiation, as RXRa is highly expressed in GM progenitors, and in terminally differentiated monocytes, but not in mature granulocytes. These data offer a potential explanation for why no myeloid phenotype was detectable in our system. RXRa must be downregulated for G-CSF-stimulated neutrophil development to proceed. Thus, functional knockdown of RXRa (as in RXRa DDB/ þ and RXRa DDB/DDB mice) would be expected to promote neutrophil differentiation, as opposed to impairing it. The findings of Taschner et al. may also help explain our hematopoeitic progenitor data. Since loss of RXRa promotes neutrophil differentiation, it is reasonable to expect that RXRa DDB/DDB mice would have increased numbers of more mature cells, which cannot be identified by a CFU assay. Thus, while NuMA-RARa þ /RXRa þ / þ and NuMA-RARa þ /RXRa DDB/DDB mice exhibit the same CFU phenotype, they may do so for different reasons. In the former case, NuMA-RARa prevents maturation of the progenitor, leading to an abortive colony; in the latter, there are fewer progenitors.
Given our data, we can postulate a model to explain our observations in the context of previous reports. NuMA-RARa is capable of sequestering RXRa (Hummel et al., 2002; Dong et al., 2004) . Functional loss of RXRa-impaired NuMA-RARa-dependent gene deregulation. We propose that both situations (NuMARARa binding to RXRa and blocking/co-opting RXRmediated signaling, and functional loss of RXRa) lead to functional abrogation of RXRa-mediated signaling. While this leads to an overproduction of neutrophil lineage cells in the BM of NuMA-RARa
mice, the presence of functional NuMA-RARa/RXRa could block neutrophil differentiation. This would account both for the leukemia in the hCG-NuMA-RARa animals, as well as for the PB and BM neutrophilia observed in those mice. Functional loss of RXRa in NuMA-RARa þ mice, as reported herein, would still lead to an overproduction of neutrophils (observed in NuMA-RARa þ /RXRa DDB/DDB mice), as RXRa-mediated signaling remains abrogated in these mice. However, in the absence of functional NuMA-RARa/RXRa, leukemia does not develop.
Our work is complementary to other lines of evidence that support the involvement of X-RARa/RXRa in leukemogenesis (Kamel-Reid et al., 2003; Kamashev et al., 2004; Zeisig et al., 2007; Zhu et al., 2007) . Indeed, our work provides in vivo evidence for the necessary role for RXRa in the transcriptional function of X-RARa. We also provide independent confirmation of the results obtained by Zhu et al. (2007) , which demonstrated the requirement for dimerization of RXRa to PML-RARa in the development of leukemia in transgenic mice. Taken together, these data support the involvement of the X-RARa/RXRa complex in APL pathogenesis, and suggest that RXRa may transcriptionally cooperate with NuMA-RARa during leukemogenesis.
Materials and methods
Characterization of mutant RXRa (RXRa
DDB
)
We characterized the subcellular localization (by western blot) and transcriptional properties of RXRa DDB (by luciferase assay; Kamel-Reid et al., 2003; Supplementary Information) .
Transgenic lines
Transgenic lines and genotyping methodologies are described in the Supplementary Information. Animals were treated in accordance with Canadian Council on Animal Care (CCAC) guidelines. Disease was diagnosed as defined (Kogan et al., 2002; Supplementary Table S1) . Persistent evidence of disease or signs of illness marked the study end point. As multiple genotype classes were involved, we phenotyped each cohort of mice independently.
Analysis of Cre-mediated excision of RXRa exon 4
We developed two PCR-based methods to assess RXRa exon 4 excision. Nonquantitative PCR utilizing primers RXR1 and RXR3 (Supplementary Figure S1B) Assessment of Cre expression by laser-scanning confocal microscopy Cytospin preparations of cells obtained from day 7 CFU-GM were made, and stained with mouse monoclonal anti-Cre (AbCam, Cambridge, MA, USA). FITC-conjugated antimouse IgG was used to visualize Cre. Slides were analyzed using a Zeiss LSM510 Laser Scanning Confocal Microscope, integrated camera and software (Carl Zeiss Canada Ltd, Toronto, Ontario, Canada), Â 63/1.2NA water immersion objective lens, at room temperature.
Phenotyping study design Six generations of animals (>400 mice) were analyzed. Mice were anesthetized in a CO 2 chamber and killed for analysis between 2 and 15 months. PB and BM differential counts and flow cytometry were carried out (Sukhai et al., 2004) . BM was also analyzed by colony-forming assays and primary culture.
Hematopoietic progenitor assays
Whole BM cells, before red cell lysis, were suspended (10 000 cells/ml) in methylcellulose medium (StemCell Technologies, Vancouver, British Columbia, Canada), containing erythropoietin, stem cell factor and interleukin-3, supplemented ±5 ng/ml G-CSF or GM-CSF, and grown at 37 1C in 5% CO 2 . Erythroid (BFU-E, erythroid burst-forming unit) and granulocyte/monocyte (CFU-GM) colonies were scored on day 7; more primitive CFU-GEMM were scored on day 12. Each colony is derived from a single progenitor cell; WT mice have B3 progenitors per 1000 cells. NuMA-RARα + RXRα ∆DB/∆DB * * * * * * Primary bone marrow culture Primary bone marrow cultures were established as described (Supplementary Information). Two days post establishment, cultures were treated with 10 ng/ml G-CSF to induce neutrophil differentiation. Cells were harvested for gene expression analysis after 72 h G-CSF incubation. WT and NuMA-RARa þ cultures were not significantly different from each other, and were composed of predominantly immature myeloid cells (Supplementary Figure S2) at time of harvest; thus, PBMCs are a useful in vitro tool for studying the effects of NuMA-RARa.
C/EBPε
Gene expression analysis by RQ-PCR RNA was isolated from PBMCs and RQ-PCR carried out using the ABI Prism 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) and SYBR Green I reaction chemistry. Experiments were performed in duplicate for each sample and were repeated when a coefficient of variation >5% was observed. Data were analyzed by the DDC t method (Livak and Schmittgen, 2001; Reis et al., 2002) . The reference was the mean DC t of WT littermate controls. Dissociation curves were performed to ensure specific amplification, and no PCR artifact.
Statistical analyses
Comparisons between two genotype classes were performed by t-test; multipopulation were made by analysis of variance. Statistical significance was defined as Po0.05.
